NVAX
Novavax·NASDAQ
--
--(--)
--
--(--)
NVAX fundamentals
Novavax (NVAX) Revenue Breakdown: Q3 2025 Business & Regional Performance
Novavax (NVAX) reported total revenue of 70.44M USD in Q3 2025, with its core business segment Product Sales contributing 19.08%. Regionally, United States remained the largest market, accounting for 80.60% of total revenue. Explore Novavax's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Novavax (NVAX) reported total revenue of 70.44M USD in Q3 2025, with its core business segment Product Sales contributing 19.08%. Regionally, United States remained the largest market, accounting for 80.60% of total revenue. Explore Novavax's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did Novavax beat or miss consensus estimates last quarter?What were the key takeaways from Novavax’s earnings call?What were the key takeaways from Novavax's earnings call?What does Novavax do and what are its main business segments?What is the market's earnings forecast for Novavax next quarter?What is Novavax's gross profit margin?What is Novavax's latest dividend and current dividend yield?What factors drove the changes in Novavax's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
